Literature DB >> 22437304

Holocord ependymoma.

Hamit Feran Gunes1, Nail Ozdemir.   

Abstract

Intramedullary tumors affecting the entire cord from the cervicomedullary junction to the conus are termed "holocord tumors". Ependymomas are the most frequent intramedullary tumor in adults. Holocord ependymoma is an exceedingly rare condition. An extensive review of the literature revealed that only five other cases have been reported. We report the sixth case of holocord ependymoma. In this article, we present a case of holocord ependymoma in a 19-year-old girl which was totally resected in a two-stage approach. A two-staged operation is recommended for the aim of total resection for this disease. Besides, cysts are common feature of all spinal ependymomas. There was a solid mass not accompanied by a cyst a any level in our patient's tumor. To the authors' best knowledge, a pure solid mass not accompanied by a cyst has not been previously reported with holocord ependymoma cases.

Entities:  

Mesh:

Year:  2012        PMID: 22437304     DOI: 10.5137/1019-5149.JTN.3281-10.1

Source DB:  PubMed          Journal:  Turk Neurosurg        ISSN: 1019-5149            Impact factor:   1.003


  3 in total

Review 1.  Fatal holocord recurrence of a pregnancy-related, low-grade spinal ependymoma: case report and review of an unusual clinical phenomenon.

Authors:  Sumit Thakar; Laxminadh Sivaraju; Nandita Ghosal; Saritha Aryan; Alangar S Hegde
Journal:  Spinal Cord Ser Cases       Date:  2020-10-02

2.  Single staged complete length excision of the holocord ependymoma: Team work.

Authors:  Kamlesh S Bhaisora; Pradeep Sharma; Arun Kumar Srivastava; Anant Mehrotra; Kuntal Kanti Das; Jayesh Sardhara; Sanjay Behari; A K Jaiswal; R N Sahu
Journal:  J Pediatr Neurosci       Date:  2015 Oct-Dec

Review 3.  Holocord oligodendroglioma with intracranial extension in a young adult: a case report and review of literature.

Authors:  Romulus Emmanuel H Cruz; Ranhel C De Roxas; Carmela Concepcion A Sales-Callangan; Roland Dominic G Jamora
Journal:  CNS Oncol       Date:  2018-02-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.